Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.
<h4>Background</h4>Hepatocellular carcinoma (HCC) is a common malignancy that has a poor prognosis because there is lack of methods for early diagnosis. We aimed to utilize two serum long non-coding RNAs (lncRNAs), uc001ncr and AX800134, to diagnose hepatitis B virus (HBV)-positive HCC.&...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144934&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849723559707934720 |
|---|---|
| author | Kang Wang Wei Xing Guo Nan Li Chun Fang Gao Jie Shi Yu Fu Tang Feng Shen Meng Chao Wu Shan Rong Liu Shu Qun Cheng |
| author_facet | Kang Wang Wei Xing Guo Nan Li Chun Fang Gao Jie Shi Yu Fu Tang Feng Shen Meng Chao Wu Shan Rong Liu Shu Qun Cheng |
| author_sort | Kang Wang |
| collection | DOAJ |
| description | <h4>Background</h4>Hepatocellular carcinoma (HCC) is a common malignancy that has a poor prognosis because there is lack of methods for early diagnosis. We aimed to utilize two serum long non-coding RNAs (lncRNAs), uc001ncr and AX800134, to diagnose hepatitis B virus (HBV)-positive HCC.<h4>Methods</h4>lncRNA microarrays were utilized to measure the differential expression of lncRNAs between tumor tissues and corresponding non-tumor tissues in HBV-positive hapatocellular carcinoma. uc001ncr and AX800134 were selected as candidate lncRNAs and detected in three independent cohorts containing a total of 684 participants (healthy individuals and chronic HBV patients and HBV-positive HCC patients) who were recruited between March 2011 and December 2012. A logistic regression model was constructed using a training cohort (n = 353) and validated using an independent cohort (n = 181). The area under the receiver operating characteristic curve (AUC) was utilized to evaluate the diagnostic accuracy.<h4>Results</h4>We determined that a panel based on the expression of uc001ncr and AX800134 accurately diagnosed HBV-positive HCC (AUC values of 0.9494 and 0.9491 for the training and validation cohorts, respectively). The diagnostic performance of the panel remained high in patients with AFP≤400 ng/ml (AUC values of 0.9371 and 0.9527 for the training and validation cohorts, respectively). The panel also diagnosed early HCC (AUC values of 0.9450 and 0.9564 for the training and validation cohorts, respectively).<h4>Conclusion</h4>Our results indicated that the serum expression of uc001ncr and AX800134 has potential as novel potential biomarker for the diagnosis of HCC, especially in patients with AFP≤400 ng/ml or early-stage disease (BCLC 0+A). |
| format | Article |
| id | doaj-art-a613a1658be148668c2a2bcbafca9c90 |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-a613a1658be148668c2a2bcbafca9c902025-08-20T03:10:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014493410.1371/journal.pone.0144934Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma.Kang WangWei Xing GuoNan LiChun Fang GaoJie ShiYu Fu TangFeng ShenMeng Chao WuShan Rong LiuShu Qun Cheng<h4>Background</h4>Hepatocellular carcinoma (HCC) is a common malignancy that has a poor prognosis because there is lack of methods for early diagnosis. We aimed to utilize two serum long non-coding RNAs (lncRNAs), uc001ncr and AX800134, to diagnose hepatitis B virus (HBV)-positive HCC.<h4>Methods</h4>lncRNA microarrays were utilized to measure the differential expression of lncRNAs between tumor tissues and corresponding non-tumor tissues in HBV-positive hapatocellular carcinoma. uc001ncr and AX800134 were selected as candidate lncRNAs and detected in three independent cohorts containing a total of 684 participants (healthy individuals and chronic HBV patients and HBV-positive HCC patients) who were recruited between March 2011 and December 2012. A logistic regression model was constructed using a training cohort (n = 353) and validated using an independent cohort (n = 181). The area under the receiver operating characteristic curve (AUC) was utilized to evaluate the diagnostic accuracy.<h4>Results</h4>We determined that a panel based on the expression of uc001ncr and AX800134 accurately diagnosed HBV-positive HCC (AUC values of 0.9494 and 0.9491 for the training and validation cohorts, respectively). The diagnostic performance of the panel remained high in patients with AFP≤400 ng/ml (AUC values of 0.9371 and 0.9527 for the training and validation cohorts, respectively). The panel also diagnosed early HCC (AUC values of 0.9450 and 0.9564 for the training and validation cohorts, respectively).<h4>Conclusion</h4>Our results indicated that the serum expression of uc001ncr and AX800134 has potential as novel potential biomarker for the diagnosis of HCC, especially in patients with AFP≤400 ng/ml or early-stage disease (BCLC 0+A).https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144934&type=printable |
| spellingShingle | Kang Wang Wei Xing Guo Nan Li Chun Fang Gao Jie Shi Yu Fu Tang Feng Shen Meng Chao Wu Shan Rong Liu Shu Qun Cheng Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma. PLoS ONE |
| title | Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma. |
| title_full | Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma. |
| title_fullStr | Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma. |
| title_full_unstemmed | Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma. |
| title_short | Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma. |
| title_sort | serum lncrnas profiles serve as novel potential biomarkers for the diagnosis of hbv positive hepatocellular carcinoma |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144934&type=printable |
| work_keys_str_mv | AT kangwang serumlncrnasprofilesserveasnovelpotentialbiomarkersforthediagnosisofhbvpositivehepatocellularcarcinoma AT weixingguo serumlncrnasprofilesserveasnovelpotentialbiomarkersforthediagnosisofhbvpositivehepatocellularcarcinoma AT nanli serumlncrnasprofilesserveasnovelpotentialbiomarkersforthediagnosisofhbvpositivehepatocellularcarcinoma AT chunfanggao serumlncrnasprofilesserveasnovelpotentialbiomarkersforthediagnosisofhbvpositivehepatocellularcarcinoma AT jieshi serumlncrnasprofilesserveasnovelpotentialbiomarkersforthediagnosisofhbvpositivehepatocellularcarcinoma AT yufutang serumlncrnasprofilesserveasnovelpotentialbiomarkersforthediagnosisofhbvpositivehepatocellularcarcinoma AT fengshen serumlncrnasprofilesserveasnovelpotentialbiomarkersforthediagnosisofhbvpositivehepatocellularcarcinoma AT mengchaowu serumlncrnasprofilesserveasnovelpotentialbiomarkersforthediagnosisofhbvpositivehepatocellularcarcinoma AT shanrongliu serumlncrnasprofilesserveasnovelpotentialbiomarkersforthediagnosisofhbvpositivehepatocellularcarcinoma AT shuquncheng serumlncrnasprofilesserveasnovelpotentialbiomarkersforthediagnosisofhbvpositivehepatocellularcarcinoma |